Icon price target lowered to $350 from $355 at Barclays

Barclays lowered the firm’s price target on Icon to $350 from $355 and keeps an Overweight rating on the shares. The analyst says there is too much focus on the overall guidance cut, as the non-COVID business is actually coming in better than originally expected. The market remains healthy as large pharma demand continues to be strong, the analyst tells investors in a research note.